...
首页> 外文期刊>BMC Medical Genetics >Rapid detection of pathological mutations and deletions of the haemoglobin beta gene ( HBB ) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR)
【24h】

Rapid detection of pathological mutations and deletions of the haemoglobin beta gene ( HBB ) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR)

机译:通过高分辨率熔解(HRM)分析和基因比率分析拷贝枚举PCR(GRACE-PCR)快速检测血红蛋白β基因(HBB)的病理突变和缺失

获取原文

摘要

Objectives Inherited disorders of haemoglobin are the world’s most common genetic diseases, resulting in significant morbidity and mortality. The large number of mutations associated with the haemoglobin beta gene ( HBB ) makes gene scanning by High Resolution Melting (HRM) PCR an attractive diagnostic approach. However, existing HRM-PCR assays are not able to detect all common point mutations and have only a very limited ability to detect larger gene rearrangements. The aim of the current study was to develop a HBB assay, which can be used as a screening test in highly heterogeneous populations, for detection of both point mutations and larger gene rearrangements. Methods The assay is based on a combination of conventional HRM-PCR and a novel Gene Ratio Analysis Copy Enumeration (GRACE) PCR method. HRM-PCR was extensively optimised, which included the use of an unlabelled probe and incorporation of universal bases into primers to prevent interference from common non-pathological polymorphisms. GRACE-PCR was employed to determine HBB gene copy numbers relative to a reference gene using melt curve analysis to detect rearrangements in the HBB gene. The performance of the assay was evaluated by analysing 410 samples. Results A total of 44 distinct pathological genotypes were detected. In comparison with reference methods, the assay has a sensitivity of 100?% and a specificity of 98?%. Conclusion We have developed an assay that detects both point mutations and larger rearrangements of the HBB gene. This assay is quick, sensitive, specific and cost effective making it suitable as an initial screening test that can be used for highly heterogeneous cohorts.
机译:目的遗传性血红蛋白疾病是世界上最常见的遗传疾病,可导致大量发病和死亡。与血红蛋白β基因(HBB)相关的大量突变使通过高分辨率熔解(HRM)PCR进行的基因扫描成为一种有吸引力的诊断方法。然而,现有的HRM-PCR测定法不能检测所有共同点突变,并且仅具有非常有限的检测较大基因重排的能力。当前研究的目的是开发一种HBB检测方法,可以将其用作高度异质性人群的筛选测试,以检测点突变和较大的基因重排。方法该测定是基于常规HRM-PCR和新型基因比率分析拷贝枚举(GRACE)PCR方法的结合。对HRM-PCR进行了广泛的优化,包括使用未标记的探针以及将通用碱基掺入引物中,以防止受到常见非病理多态性的干扰。使用熔解曲线分析来检测HBB基因中的重排,使用GRACE-PCR确定相对于参考基因的HBB基因拷贝数。通过分析410个样品来评估分析的性能。结果共检出44种不同的病理基因型。与参考方法相比,该测定法的灵敏度为100%,特异性为98%。结论我们开发了一种检测HBB基因的点突变和较大重排的检测方法。该测定快速,灵敏,特异且具有成本效益,使其适合作为可用于高度异质队列的初始筛选测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号